• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Winthrop P. Rockefeller Cancer Institute: Patients and Family
  • UAMS Health
  • Jobs
  • Giving
  • Finding Your Way
    • Prepare for Your First Visit
    • Maps and Directions
    • Accommodations
    • Dining
    • Gift Shop
    • Services & Amenities
  • Treatment
    • Cancer Institute Clinical Resources
    • Clinical Trials
    • Clinics and Centers
    • myChart
    • Appointments
    • Cancer Types
    • Treatment Options
    • Cancer Survivorship Programs
  • Prevention
    • Genetics Program
    • Quit Smoking Programs
    • Lung Cancer Screening
    • Colorectal Cancer Screenings
    • MammoVan
  • Patient Support
    • Support Groups
    • Social Workers
    • Financial Counseling
    • Pharmacist
    • Cancer Nutrition Services
    • Pastoral Care
  1. University of Arkansas for Medical Sciences
  2. Winthrop P. Rockefeller Cancer Institute
  3. Patients and Family
  4. National Breast Cancer Screening Trial

National Breast Cancer Screening Trial

Gwendolyn Bryant-Smith, M.D., chief of breast imaging at UAMS and local principal investigator for the trial
Gwendolyn Bryant-Smith, M.D., chief of breast imaging at UAMS and local principal investigator for the trial

The UAMS Winthrop P. Rockefeller Cancer Institute is participating in the National Cancer Institute’s TMIST (Tomosynthesis Mammographic Imaging Screening Trial).

The study compares two standard breast cancer screening methods: tomosynthesis (3D) mammograms and digital (2D) mammograms, and is designed to help researchers determine whether one method is better than the other at finding life-threatening breast cancers.

The study involves 100 clinics and includes 165,000 women in the United States and Canada. The UAMS Breast Center has enrolled 290 participants to date and is able to include even more women.

“By participating in this research study, you can help determine the most effective type of mammogram and how often women should receive screening,” said Gwendolyn Bryant-Smith, M.D., chief of breast imaging at UAMS and local principal investigator for the trial.

In a briefing held Oct. 7, NCI leaders stated, “We need women to take part to make sure breast cancer screening of the future is appropriate for all women. October is Breast Cancer Awareness Month, a time to share the importance of screening mammograms and early detection.”

The UAMS TMIST study coordinator is available at (501) 400-3195 or TMISTstudy@uams.edu for anyone wanting to learn more about the study.

Women ages 45 to 74 who plan to get a routine screening mammogram at the UAMS Breast Center are eligible for this trial. Participants are randomly assigned to get either a 3D or 2D mammogram every one or two years for the first five years of the study. Researchers will follow each woman’s breast cancer status for a total of eight years by reviewing medical records and possibly conducting phone interviews.

TMIST was developed by the Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) Cancer Research Group and the National Cancer Institute, part of the National Institutes of Health. ECOG-ACRIN leads the trial.

Posted by Chadley Uekman on October 12, 2021

Filed Under: Clinical Trials

Winthrop P. Rockefeller Cancer Institute LogoWinthrop P. Rockefeller Cancer InstituteWinthrop P. Rockefeller Cancer Institute
Address: 449 Jack Stephens Dr., Little Rock, AR 72205
Parking Deck: 4018 W Capitol Ave., Little Rock, AR 72205
Appointments: (501) 296-1200
Referring Physicians: (501) 686-6080
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy

© 2023 University of Arkansas for Medical Sciences